Protagonist Therapeutics, Inc

Ownership Transactions Reported by 13 Insiders

Symbol
PTGX on Nasdaq
Location
7707 Gateway Blvd., Suite 140, Newark, CA

Insiders trading volume in the past year

Protagonist Therapeutics, Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Dinesh V. Patel President and CEO, Director $18M -$4.39M -19.6% Jun 13, 2024
Suneel Gupta Chief Development Officer $5.41M -$125K -2.26% Feb 26, 2024
David Y. Liu Chief R&D Strategy Officer $4.13M Nov 16, 2022
Arturo Molina Chief Medical Officer $1.19M -$30K -2.46% Jan 16, 2024
Asif Ali Chief Financial Officer $933K -$795K -46% Apr 18, 2024
William D. Waddill Director $540K -$1.37M -71.7% Sep 10, 2024
Donald A. Kalkofen Chief Financial Officer $456K Feb 15, 2022
Harold E. Selick Director $52.9K Mar 7, 2024
Sarah B. Noonberg Director Jan 16, 2023
Bryan Giraudo Director Jan 2, 2024
Lewis T. Williams Director Jan 2, 2024
Sarah A. O'Dowd Director Jan 2, 2024
Daniel N. Swisher JR Director Oct 26, 2023

Recent Insider Transactions by Companies or Individuals for Protagonist Therapeutics, Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.